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ABSTRACT
Synthetic small duplex RNAs that are fully comple-
mentary to gene promoters can silence transcrip-
tion in mammalian cells. microRNAs (miRNAs) are
endogenous small regulatory RNAs that sequence
specifically regulate gene expression. We have de-
veloped a computational method to identify poten-
tial miRNA target sites within gene promoters. Ten
candidate miRNAs predicted to target the human
progesterone receptor (PR) gene promoter were
tested for their ability to modulate gene expression.
Several miRNA mimics inhibited PR gene expression
and miR-423-5p, which targets a highly conserved
region of the PR promoter, was chosen for detailed
analysis. Chromatin immunoprecipitation revealed
that the miR-423-5p mimic decreased RNA polymer-
ase II occupancy and increased histone H3 lysine 9
dimethylation (H3K9me2) at the PR promoter, indi-
cative of chromatin-level silencing. Transcriptional
silencing was transient, independent of DNA
methylation, and associated with recruitment of
Argonaute 2 (AGO2) to a non-coding RNA (ncRNA)
transcript that overlaps the PR gene promoter. The
miR-423-5p mimic also silenced expression of im-
munoglobulin superfamily member 1 (IGSF1), an
additional gene with a predicted target site within
its promoter. While additional investigations of en-
dogenous miRNA function will be necessary, these
observations suggest that recognition of gene pro-
moters by miRNAs may be a natural and general
mechanism for regulating gene transcription.
INTRODUCTION
Small duplex RNAs complementary to gene promoters
are potent silencers and activators of target gene
expression in mammalian cells (1–12). We and others
have demonstrated that these small RNAs sequence spe-
ciﬁcally recognize non-coding RNA (ncRNA) transcripts
that overlap gene promoters (6,12–15). Recognition of the
target ncRNA occurs in close proximity to the chromo-
some and leads to recruitment of Argonaute (AGO)
proteins to the ncRNA and to the target gene promoter
(13,14,16–18). Modulation of target gene expression
occurs at the level of transcription and has been
observed in both the presence and absence of DNA
methylation (1–7).
Potent and robust transcriptional modulation suggests
the existence of an endogenous mechanism that facilitates
recognition of gene promoters by small RNAs. AGO
proteins implicated in the mechanism of promoter-
targeting RNAs are conserved across eukaryotes (19).
AGO proteins have been shown to use endogenous
small RNAs to direct chromatin modiﬁcation and
regulate transcription in yeast and plants (20–22).
In humans, AGO proteins are well known for their role
in microRNA (miRNA) regulation. miRNAs are an en-
dogenous class of short regulatory RNAs ranging
in length from 19 to 30 bases. They are generally under-
stood to repress gene expression post-transcriptionally
through recognition of sequences within 30-UTRs of
mRNA transcripts (23,24). miRNAs have been re-
ported to regulate transcription in human cells, but
much remains to be learned about their mechanism of
action (25,26).
We previously performed a genome-wide evaluation of
gene promoters and found a signiﬁcant enrichment of
putative miRNA target sites within promoter regions
(27). Using the human progesterone receptor (PR) as a
model gene we have now identiﬁed multiple miRNA
mimics that are predicted to target the PR promoter and
inhibit PR expression. We further demonstrate that a
ncRNA transcribed from the PR promoter serves as the
molecular target of these miRNA mimics. Our results
indicate that miRNA recognition of gene promoters may
be a general mechanism for gene regulation.
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Cell culture
T47D and MCF7 breast cancer cells [American Type
Culture Collection (ATCC)] were maintained in
RPMI-1640 medium (ATCC) supplemented with 10%
(v/v) FBS (Atlanta Biologicals), 0.5% (v/v) nonessential
amino acids (Sigma), 10mM HEPES (Sigma), 1mM
Sodium Pyruvate (Sigma), 0.4 U/ml bovine insulin
(Sigma). Cells were cultured at 37 C and 5% CO2.
Cellular delivery of miRNA mimics and siRNAs
RNAiMAX (Invitrogen) was used to deliver small duplex
RNAs into T47D or MCF7 cells as per the manufacturer’s
instructions. For RNA and protein isolation, cells were
plated in six-well dishes at densities ranging between 150
and 200K cells/well. For RNA and chromatin
immunoprecipitation, cells were plated in 10cm
2 dishes
at a density of 4.5 10
6 cells/dish. Cells were transfected
48h after plating. A double transfection protocol was used
for AGO reversal experiments. The ﬁrst transfection was
performed as described above (using mismatch-containing
duplexes or siRNAs against AGO). After 72h, cells were
dissociated using trypsin and re-seeded in transfection
reagent (using MM, miR-423-5p or pre-miR-423
duplexes). Sequences for miRNA mimics and siRNAs
are listed in Supplementary Table S1A.
Western blotting
Cells were harvested 5 days post-transfection for protein
isolation. Cell pellets were lysed and protein concentra-
tions were quantiﬁed by BCA assay (Pierce). Western
blots were performed on protein lysates (30mg/well).
Primary antibodies used were a-PR (Cell Signalling
Technology) and a-b-actin (Sigma). Protein was visualized
with horseradish peroxidase-conjugated a-mouse second-
ary antibody (Jackson Immunolabs) and Supersignal de-
veloping solution (Pierce).
Quantitative PCR
Cells were harvested 72h post-transfection for RNA iso-
lation. RNA was isolated using TRI Reagent (Sigma) as
per the manufacturer’s instructions. For each sample, 2mg
of RNA was reverse transcribed using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems).
RNA was treated with DNase I (Worthington) prior to
reverse transcription. qPCR was performed on an
ABI7900 real-time PCR (Applied Biosystems) using iTaq
SYBR Green Supermix (Bio-Rad). ABI TaqMan miRNA
assays were used to detect miR-423-5p and U6 snRNA as
per the manufacturer’s instructions. Primers for PR and
GAPDH mRNA were supplied by Applied Biosystems.
All additional primers were designed using Primer3.
Only those primer sets that showed linear ampliﬁcation
over several orders of magnitude were used for quantiﬁ-
cation. Primers and PCR conditions are listed in
Supplementary Table S1B.
Chromatin immunoprecipitation and RNA
immunoprecipitation
Chromatin immunoprecipitation (ChIP) and RNA
immunoprecipitation (RIP) were performed essentially as
described (28). Cells were harvested 72h post-transfection.
a-RNA Polymerase II, a-H3K9me2, a-AGO1, a-AGO2,
normal rabbit IgG and normal mouse IgG antibodies were
supplied by Millipore. For RIP, isolated RNA was treated
with DNase I and reverse transcribed. Primers for the PR
promoter and GAPDH promoter were designed using
Primer3. Only those primer sets that showed linear amp-
liﬁcation over several orders of magnitude were used for
quantiﬁcation. Primers and PCR conditions are listed in
Supplementary Table S1B.
Methylation speciﬁc PCR and bisulphite sequencing
Genomic DNA was extracted using TRI Reagent (Sigma)
as per the manufacturer’s instructions. For each sample,
2mg of DNA was diluted into 50mlo fH 2O.
Single-stranded DNA was created by adding 5.5mlo f2
M NaOH and incubating at 37 C for 10min. To each
sample, 30ml of freshly prepared 10mM hydroquinone
(Sigma) and 520ml of freshly prepared 3 M sodium
bisulphite (Sigma) were added. DNA was incubated at
50 C for 16h. After bisulphite treatment, DNA was
puriﬁed using the Wizard DNA Clean-Up System
(Promega). DNA was then subjected to ammonium
acetate precipitation and ethanol washing to remove any
remaining impurities. PCR ampliﬁcation of treated DNA
was performed using HotStarTaq DNA polymerase
(QIAGEN) as per the manufacturer’s instructions.
Primers and PCR conditions are listed in Supplementary
Table S1B. PCR products were resolved on 3% agarose
gel with ethidium bromide. For bisulphite sequencing
PCR products were cloned into a PCR-4 Topo vector
(Invitrogen) and sequenced (McDermott sequencing
core, University of Texas, Southwestern).
Statistical Analysis
Data are presented as means±standard deviation of
three or more independent results. Statistical signiﬁcance
was assessed using a two-tailed unpaired Student’s t-test.
RESULTS AND DISCUSSION
miRNAs complementary to the PR promoter inhibit PR
expression
We have previously designed small duplex RNAs comple-
mentary to the PR promoter and demonstrated that these
RNAs silence transcription of the PR gene (4,16). We
subsequently showed that the molecular targets of these
small RNAs are ncRNA transcripts produced from the
PR promoter (14). The PR gene has two major isoforms
termed PR-B and PR-A that differ in their transcription
start sites (TSS), PR-B being the most upstream. One of
the ncRNAs that we characterized is a 2170-base tran-
script that initiates 1431 bases downstream of the PR-B
TSS and is transcribed in the antisense direction through
the PR promoter.
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duplex RNAs that were fully complementary to the PR
promoter. The differences between fully complementary
designed RNAs and miRNAs are substantial. miRNAs,
which are encoded within the genome, do not require
complete complementarity to achieve target recognition.
This makes it difﬁcult to accurately predict sequences
miRNAs will efﬁciently target.
To begin to experimentally determine if miRNAs are
capable of recognizing sequences within gene promoters,
we obtained sequences for all known human miRNAs
from miRBase, the public repository for miRNAs (29).
Using an algorithm we developed to identify potential
miRNA target sites, we scanned the segment of the
ncRNA that overlaps the PR-B promoter for
potential miRNA target sites (27). We identiﬁed 72 poten-
tial miRNA target sites within the analysed region of the
ncRNA transcript. We selected 10 miRNAs for experi-
mental validation based on complementarity to their re-
spective target sequences within the PR promoter
(Figure 1A and Supplementary Figure S1). We designed
miRNA mimics that consisted of the miRNA sequence
and a fully complementary RNA carrier strand. The
miRNA mimics were transfected into T47D breast
cancer cells and PR protein expression was monitored
by western blot. PRC1 (an siRNA targeting PR mRNA)
and PR9 (a duplex RNA previously shown to target the
PR promoter and inhibit PR expression) were used as
positive controls. As a negative control we used a mis-
matched duplex RNA (MM) that does not affect PR
expression.
Several miRNA mimics inhibited PR protein expression
(Supplementary Figure S2A). Quantiﬁcation of replicate
experiments revealed that inhibition by miR-372,
miR-373, miR-520c-3p and miR-423-5p was statistically
signiﬁcant (Figure 1B). These results indicate that
miRNAs complementary to the PR promoter are
capable of inhibiting PR expression. In striking contrast
to our prior experience with designed synthetic small
RNAs, where introduction of more than one mismatched
base between the silencing RNA and its target completely
abolished activity, all of the miRNA mimics that inhibited
PR expression were extensively mismatched when aligned
to the target ncRNA (Supplementary Figure S1). For
example, miR-423-5p possesses seven mismatched bases
relative to its ncRNA target, including a three base
bulge adjacent to the seed sequence. miR-520c-3p also
contains seven-mismatched bases relative to the target
ncRNA, but with a ﬁve base bulge immediately following
the seed sequence.
The target sites for the inhibitory miRNA mimics also
differ signiﬁcantly from the sites we have previously
targeted with fully complementary small duplex RNAs.
In our prior studies, any duplexes that targeted more
than 26 bases upstream of the PR-B TSS were inactive
(4). However, three of the inhibitory miRNA mimics we
identiﬁed target more than 500 bases upstream of the TSS.
This suggests that small RNAs can target sequences much
further upstream of the PR TSS than has previously been
appreciated. The most potent mimic, miR-423-5p, targets
the region spanning from 59 bases upstream of the PR-B
TSS to 37 bases upstream of the TSS. miR-423-5p in-
hibited PR expression in a dose dependent manner with
an IC50 of 7.2nM (Figure 1C and Supplementary
Figure S2B) and was selected as the focus for subsequent
experiments.
miR-423-5p inhibits transcription of the PR gene
Potent inhibition of PR expression by the miR-423-5p
mimic prompted us to investigate the mechanism of
silencing. Using quantitative RT–PCR (RT–qPCR) we
found that the miR-423-5p mimic reduced PR mRNA
levels by >70% (Figure 2A). To evaluate whether
decreased mRNA levels are due to reduced transcription,
we monitored expression of pre-spliced mRNA, also
termed heteronuclear RNA (hnRNA), produced from
the PR locus. The miR-423-5p mimic-reduced hnRNA
levels by nearly 70% (Figure 2B). We also quantiﬁed
RNA Polymerase II (Pol II) occupancy at the PR
promoter using chromatin immunoprecipitation followed
by quantitative PCR (ChIP-qPCR). Treatment with the
miR-423-5p mimic resulted in a >60% decrease in Pol II
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Figure 1. miRNAs complementary to the PR promoter inhibit PR
expression. (A) Schematic of selected miRNAs complementary to the
PR promoter. (B) Quantiﬁcation of three independent experiments
measuring reduction of PR protein expression by miRNA mimics.
(C) Dose-dependent inhibition of PR by miR-423-5p. miRNA mimics
were added to cells at 50nM unless otherwise noted. Error bars
indicate SD (n=3). P-values were calculated using the two-tailed
unpaired Student’s t-test with equal variances. *P<0.05, **P<0.01,
***P<0.001.
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duplex (Figure 2C). Transcriptional silencing by small
RNAs has been associated with induction of repressive
histone marks, including dimethylation of histone H3
lysine 9 (H3K9me2) (17). Using ChIP-qPCR we
observed a 2.3-fold increase in H3K9me2 following treat-
ment with the miR-423-5p mimic (Figure 2D). Taken
together, these results suggest that miR-423-5p represses
transcription of the PR gene.
To ensure that inhibition of PR by miR-423-5p was not
an artefact of our miRNA mimic design, we designed a
pre-miR-423 mimic. The pre-miR-423 mimic retained the
structure of endogenous miR-423 after DICER processing
(an imperfect duplex RNA consisting of both the
miR-423-5p and miR-423-3p sequences) (Figure 3A).
Inhibition of PR expression by the pre-miR-423 mimic
was indistinguishable from the miR-423-5p mimic
(Figure 3B).
In parallel to miR-423-5p, we tested additional inhibi-
tory miRNA mimics miR-372, miR-373 and miR-520c-3p
for their effects on expression of PR mRNA. All three
mimics reduced PR mRNA expression by>70%
(Supplementary Figure S2C). The mimics also reduced
levels of PR hnRNA expression (Supplementary
Figure S2D). The ability of multiple promoter-targeting
miRNA mimics to inhibit PR expression suggests that
recognition of gene promoter sequences may be a
general property of miRNAs.
Sequence analysis of the miR-423-5p target site within
the PR promoter
miR-423-5p has a high degree of complementarity to an
antisense transcript that overlaps the PR gene promoter
(Figure 4A). The region of complementarity spans from
59 bases upstream of the PR TSS through 37 bases
upstream of the TSS. PhastCons analysis of the multiz
alignment of 44 vertebrate species revealed that this
region of the PR promoter is highly conserved, implying
that the target sequence is of biological importance
(Figure 4B).
A major determinant of miRNA target recognition is
complete complementarity between the miRNA seed
sequence (bases 2–8 of the mature miRNA) and the
target RNA sequence. One component of the algorithm,
we used to identify candidate miRNAs was the require-
ment for seed sequence complementarity with the ncRNA
overlapping the PR promoter. Interestingly, we observed
that the entire miR-423-5p seed sequence target site is
highly conserved within the PR promoter. In addition to
seed sequence complementarity, we noted two additional
regions of complementarity between miR-423-5p and the
ncRNA (Figure 4A).
To determine the importance of each segment of com-
plementarity on gene silencing, we designed mutant
miRNA mimics that contained three-base changes in
either the seed sequence (Seed-MM), the middle region
of complementarity (Mid-MM) or the terminal region of
complementarity (End-MM) (Figure 4C). We used RT–
qPCR to measure expression of PR mRNA following
treatment with each mutant miRNA mimic. Mutating
the seed sequence abolished silencing activity while
mutating the middle or end regions of complementarity
had little or no effect on silencing, respectively
(Figure 4D). Identical results were obtained when
evaluating the effects of these mutant mimics on PR
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Figure 2. miR-423-5p inhibits PR transcription. (A and B) RT–qPCR
showing inhibition of (A) PR mRNA and (B) PR hnRNA expression
by miR-423-5p. (C and D) ChIP-qPCR analysis of (C) RNA Pol II and
(D) H3K9me2 occupancy on the PR promoter following treatment with
miR-423-5p. miRNA mimics were added to cells at 25nM for RT–
qPCR and 50nM for ChIP-qPCR. Error bars indicate SD (n=3).
P-values were calculated using the two-tailed unpaired Student’s t-test
with equal variances. **P<0.01.
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423 duplex (seed sequences shown in lower case). (B) RT–qPCR
showing inhibition of PR mRNA by pre-miR-423. Error bars
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These results are consistent with known targeting
properties of miRNAs and demonstrate that the seed
sequence of miR-423-5p is a major determinant of target
recognition.
It has been reported that speciﬁc cellular RNAs are
capable of sequestering DNA binding transcription
factors (30). To test whether miR-423-5p sequesters-
speciﬁc protein factors that normally recognize the
conserved DNA sequence within the PR promoter, we
designed a small duplex DNA corresponding to the
miR-423-5p sequence. The miR-423-5p DNA duplex did
not affect PR mRNA expression, indicating that tran-
scriptional silencing is speciﬁc to small RNAs and most
likely not a result of sequestering putative DNA binding
proteins (Figure 4E).
Mechanism of miRNA-induced transcriptional silencing
Small RNA-induced transcriptional silencing has been
reported in both the presence and absence of DNA methy-
lation (1–7). There is a CpG island near the PR-B TSS
that has the potential to become methylated. We examined
the methylation state of this CpG island using bisulphite
treatment followed by methylation speciﬁc PCR (MSP).
As a positive control we used genomic DNA isolated from
MDA-MB-231 breast cancer cells where the PR promoter
is methylated. Treatment with the miR-423-5p mimic did
not induce DNA methylation at the PR promoter
(Figure 5A). Bisulphite sequencing conﬁrmed the lack of
DNA methylation throughout the PR promoter
(Figure 5B). Consistent with the absence of DNA methy-
lation, silencing of PR protein expression by miR-423-5p
was transient, lasting  7–8 days before beginning to
return to normal levels (Figure 5C). The mechanism of
transcriptional silencing by miR-423-5p at the PR
promoter does not appear to involve induction of perman-
ent epigenetic changes.
We have previously demonstrated that synthetic small
duplex RNAs targeting the PR promoter recruit AGO2 to
the antisense ncRNA transcript overlapping the PR
promoter (16,18). Likewise, other groups have reported
the involvement of AGO1 in small RNA-induced tran-
scriptional gene silencing (17). We used RIP to evaluate
both AGO1 and AGO2 occupancy on the ncRNA follow-
ing treatment with the miR-423-5p mimic. RIP revealed
no association between AGO1 and the ncRNA under any
treatment condition (Figure 6A). Conversely, treatment
with the miR-423-5p mimic resulted in association of
AGO2 with the ncRNA transcript (Figure 6B). We used
RT–qPCR to determine if recruitment of AGO2 affected
expression of the ncRNA overlapping the PR promoter.
Addition of the miR-423-5p mimic resulted in a 30%
decrease in expression of the ncRNA suggesting that the
miRNA moderately destabilized the target ncRNA
(Supplementary Figure S5). These results indicate that
the ncRNA that overlaps the PR promoter is a target
for the miR-423-5p mimic.
To further evaluate the necessity of AGO proteins for
inhibiting PR by the miR-423-5p mimic we used siRNAs
to knock down expression of either AGO1 or AGO2 prior
to miRNA mimic addition (Figure 6C and E). Depletion
of AGO1 had no effect on PR expression or the inhibition
of PR by miR-423-5p (Figure 6D). Knockdown of AGO2
caused a 2-fold increase in PR expression (Figure 6F).
While we routinely observe a 75% decrease in PR expres-
sion by miR-423-5p, PR expression was only reduced by
35% in an AGO2 depleted background. AGO2 expression
was required for inhibition by both the miR-423-5p mimic
and the pre-miR-423 mimic suggesting that our mimic
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Figure 4. Inhibition of PR by miR-423-5p requires seed sequence com-
plementarity. (A) Alignment of miR-423-5p with ncRNA overlapping
the PR promoter (seed sequence shown in lower case). (B) PhastCons
conservation analysis of the miR-423-5p target site within the PR
promoter (seed sequence target site underlined, sequence listed 30 to
50). (C) Alignment of mutant miR-423-5p mimics with ncRNA
overlapping the PR promoter (mismatched bases underlined).
(D) RT–qPCR measuring PR mRNA expression following treatment
with mutant miR-423-5p mimics. (E) RT–qPCR measuring PR mRNA
expression following treatment with a DNA analog of miR-423-5p.
Duplexes were added to cells at 25nM. Error bars indicate SD
(n=3). P-values were calculated using the two-tailed unpaired
Student’s t-test with equal variances. **P<0.01.
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of PR expression (Figure 6D and F).
Effects of miR-423-5p inhibition on PR expression
Our approach in this investigation has been to screen for
miRNAs that are capable of silencing transcription using
miRNA mimics as a proof-of-principle for miRNA-
induced transcriptional silencing and subsequently charac-
terize the mechanism of action. An alternative approach
would be to inhibit endogenously expressed miRNAs and
evaluate the effects on expression of genes that contain
predicted target sites within their promoters. This is
more complicated because in addition to the computation-
al target predictions, knowledge about endogenous
miRNA expression is required and the endogenous
control pathway must be present in the cell types used
for the experiment. Furthermore, the tools available for
inhibiting miRNAs are not as well characterized as those
for mimicking their function. However, miR-423-5p is ex-
pressed at detectable levels in T47D cells so we evaluated
whether the endogenous miRNA was regulating PR
expression.
To inhibit the function of endogenous miR-423-5p, we
designed an antisense 20-O-methyl RNA that was fully
complementary to the miRNA (anti-miR). As controls
we also designed 20-O-methyl RNAs consisting of either
mismatched (MM) or scrambled (SCR) derivatives of
the anti-miR sequence. RT–qPCR conﬁrmed that
addition of the anti-miR signiﬁcantly reduced detection
of miR-423-5p (Supplementary Figure S4A). Inhibition
of miR-423-5p did not affect PR mRNA expression
(Supplementary Figure S4B). This result is not particu-
larly surprising as T47D cells express high basal levels of
the PR gene and it is unlikely that the gene is under
miRNA-mediated repression in this cell line.
The PR gene is expressed at low basal levels in MCF7
breast cancer cells and we reasoned that it might be a
better cell line for studying the effects of endogenous
miRNAs on PR expression. Using RT–qPCR, we were
able to detect miR-423-5p expression in MCF7 cells and
used the anti-miR to inhibit the function of the endogen-
ous miRNA (Supplementary Figure S4C). Addition of the
anti-miR had no effect on PR mRNA expression
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Figure 6. Inhibition of PR expression by miR-423-5p is mediated by
AGO2. (A and B) RIP analysis of (A) AGO1 and (B) AGO2 recruit-
ment to the ncRNA overlapping the PR promoter by miR-423-5p.
(C) RT–qPCR analysis of AGO1 mRNA expression following treat-
ment with siRNA against AGO1. (D) RT–qPCR analysis of PR
mRNA inhibition by miR-423-5p following AGO1 knockdown.
(E) RT–qPCR analysis of AGO2 mRNA expression following treat-
ment with siRNA against AGO2. (F) RT–qPCR analysis of PR mRNA
inhibition by miR-423-5p following AGO2 knockdown. TF1=
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were added to cells at 25nM for AGO reversal experiments and
50nM for RIP. Error bars indicate SD (n=3). P-values were
calculated using the two-tailed unpaired Student’s t-test with equal
variances. **P<0.01.
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Figure 5. Mechanism of miR-423-5p-induced silencing of PR.
(A) Methylation speciﬁc PCR of the PR promoter after treatment
with miR-423-5p. U, unmethylated. M, methylated. (B) Bisulphite
sequencing of the PR promoter following addition of miR-423-5p.
Open circles, unmethylated CpG. Closed circles, methylated CpG.
Circles represent individual CpG dinucleotides. (C) Timecourse of
PR inhibition by miR-423-5p. miRNA mimics were added to cells
at 25nM.
Nucleic Acids Research, 2011,Vol.39, No. 13 5687(Supplementary Figure S4D). These data suggest that
while miR-423-5p is capable of silencing transcription of
the PR gene, the endogenous miRNA is not performing
this function in the cell lines we tested and that a physio-
logical role for miR-423-5p in PR regulation, if any, will
be found in other cell types or under other physiologic
conditions.
Generality of miRNA-induced transcriptional silencing
The potency of miR-423-5p-induced silencing of the PR
gene in T47D cells led us to test the effect of synthetic
miR-423-5p on PR expression in MCF7 cells. MCF7
cells express PR at low basal levels as compared with
T47D cells (9). We transfected miR-423-5p into MCF7
cells and monitored PR expression. Western blot
revealed that the miR-423-5p mimic inhibited PR
protein expression (Figure 7A). Using RT–qPCR, we
observed a >60% reduction in PR mRNA expression
(Figure 7B). In addition, the miR-423-5p mimic resulted
in a >70% reduction in PR hnRNA levels (Figure 7C).
These data demonstrate that miRNA-induced transcrip-
tional silencing of PR is readily observed in two human
cell lines with differing basal levels of PR expression.
To further establish the generality of miRNA-induced
transcriptional silencing, we searched for additional genes
with miR-423-5p target sites within their promoters.
Sequence analysis revealed a miR-423-5p target site
within a conserved region of the immunoglobulin super-
family member 1 (IGSF1) gene promoter (Figure 8A).
miR-423-5p is complementary to a putative promoter-
overlapping ncRNA transcribed in the antisense direction
relative to the IGSF1 gene at a region spanning from 36 to
8 bases upstream of the IGSF1 TSS. IGSF1 is expressed at
very low levels in T47D cells; however, RT–PCR readily
detected expression of IGSF1 mRNA in MCF7 cells
(Figure 8B). We also detected expression of an RNA
species overlapping the IGSF1 promoter that included
the miR-423-5p target sequence (Figure 8B).
We transfected the miR-423-5p mimic into MCF7 cells
and monitored IGSF1 expression using RT–qPCR. We
observed a 60% reduction in IGSF1 mRNA expression
after treatment with miR-423-5p (Figure 8C). In addition,
miR-423-5p caused a >70% reduction in IGSF1 hnRNA
levels (Figure 8D). We next tested the effects of our pre-
viously designed mutant miR-423-5p mimics on IGSF1
mRNA expression (Figure 8E). Just as we observed with
PR, silencing of IGSF1 by miR-423-5p required seed
sequence complementarity to the predicted target RNA
(Figure 8F). Also consistent with our previous results, ex-
pression of IGSF1 was signiﬁcantly inhibited by pre-miR-
423 (Figure 8G). These results underscore the potential of
single miRNAs to target multiple gene promoters and
regulate transcription.
Transcriptional regulation by miRNAs
miRNAs are powerful regulators of gene expression that
function by recognizing complementary RNA sequences.
The vast majority of studies on miRNAs have focused on
their ability to target sequences within mRNA. Here we
show that miRNAs can also recognize ncRNAs
overlapping gene promoters and regulate transcription.
We have identiﬁed multiple promoter-targeting miRNA
mimics that inhibit PR expression, suggesting that tran-
scriptional regulation may be a general property of
miRNAs. We have also characterized one miRNA
mimic in detail and demonstrated that it can target add-
itional gene promoters, further supporting the possibility
that recognition of gene promoters by miRNAs may be a
general mechanism of gene regulation.
In this study, we have used exogenously added miRNA
mimics and have demonstrated their ability to act as
potent transcriptional regulators. We chose the mimic
approach because we anticipated that the mechanism of
transcriptional regulation would be complex. Using
miRNA mimics complementary to the PR promoter
allowed us to take advantage of our previous detailed
characterization of transcription at the PR locus and es-
tablished assays for studying the regulation PR expres-
sion. As a result, we identiﬁed several miRNA mimics
that inhibit PR expression with potencies that are
similar to those previously observed with our designed
fully complementary RNAs.
While the addition of exogenous miR-423-5p resulted in
potent inhibition of PR transcription, we did not observe a
role for endogenous miR-423-5p in regulating PR expres-
sion in the two cell lines used in this study (Supplementary
Figure S4). It is possible that there is an expression thresh-
old that must be surpassed by miRNAs before they can
function as transcriptional regulators. This would be con-
sistent with a recent study in the moss Physcomitrella
patens showing that miRNAs can induce transcriptional
silencing, but only under conditions where the speciﬁc
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Figure 7. Inhibition of PR expression by miR-423-5p in MCF7 cells.
(A) Western analysis of PR expression following treatment with
miR-423-5p in MCF7 cells. (B and C) RT–qPCR showing inhibition
of (B) PR mRNA and (C) PR hnRNA expression by miR-423-5p in
MCF7 cells. miRNA mimics were added to cells at 25nM. Error bars
indicate S.D. (n=3). P-values were calculated using the two-tailed
unpaired Student’s t-test with equal variances. **P<0.01.
5688 Nucleic Acids Research, 2011,Vol.39, No. 13miRNAs become highly expressed (31). Identifying en-
dogenous miRNAs that target gene promoters remains
an important goal and will require more complex
screening approaches covering many genes, cell types
and miRNAs. The mechanistic data provided here
should assist in designing those experiments.
Our ﬁndings here differ from our previous observations
of transcriptional silencing by designed small RNAs. For
example, our earlier reports focused on the region
spanning just 50 bases upstream of the PR-B TSS and
no duplexes that targeted more than 26 bases upstream
of the TSS were active. However, three of the inhibitory
miRNA mimics we have identiﬁed here target more than
500 bases upstream of the TSS (Figure 1A). This report is
also the ﬁrst time we have used duplex RNAs with two
imperfectly complementary RNA strands and observed
gene silencing (Figure 3A and B). This result demonstrates
that small duplex RNAs do not require full
complementarity to be processed by the RNAi machinery
for transcriptional silencing.
Perhaps the most striking observation in our current
study is the degree of imperfect complementarity
between the inhibitory miRNA mimics and their target
ncRNA. In our prior studies, we designed small duplex
RNAs that were fully complementary to the PR promoter
and the activity of these silencing RNAs was completely
abolished when duplexes contained more than one mis-
matched base from their target sequence (4). In contrast,
all of the inhibitory miRNA mimics we identiﬁed were
extensively mismatched relative to their target sequence
(Supplementary Figure S1).
Small RNAs with imperfect complementarity to their
targets face challenges that differ substantially from
those that have full complementarity. miRNAs with im-
perfect complementarity likely have greatly reduced
afﬁnity for their target sequences (as compared with
fully complementary RNAs) which would increase their
difﬁculty achieving potent and selective binding to
targets. To overcome this hurdle, at least in the case of
traditional miRNA targeting, 30-UTRs containing
miRNA binding sites with poor complementarity often
have multiple miRNA binding sites within the same
UTR to promote cooperativity (32). The miRNAs
identiﬁed in our study, in contrast, are potent inhibitors
of transcription despite having several mismatched bases
with their target sequences and only one target site within
the ncRNA. This result implies that the rules for miRNA
target recognition within promoter regions may differ with
respect to target site multiplicity and cooperativity.
There have been previous reports of miRNA mimics
targeting gene promoters in human cells. The ﬁrst report
of a promoter-targeting miRNA, from Place et al. (25),
showed that introduction of exogenous miR-373 induced
expression of two genes that contain promoter regions
with complementarity to the miRNA. Subsequently,
Kim et al. (26) reported that miR-320 targets its own
genomic location in cis and silences transcription of an
adjacent gene, POLR3D through an AGO1-dependent
mechanism. Our data differ signiﬁcantly from these
previous results. Because miR-320 targets its own
genomic location, it inherently has full complementarity
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Figure 8. Inhibition of IGSF1 expression by miR-423-5p.
(A) PhastCons conservation analysis of the miR-423-5p target site
within the IGSF1 promoter (seed sequence target site underlined,
sequence listed 30 to 50). (B) RT–PCR detection of IGSF1
promoter-overlapping ncRNA and mRNA expression. (C and D)
RT–qPCR showing inhibition of (C) IGSF1 mRNA and (D) IGSF1
hnRNA expression by miR-423-5p. (E) Alignment of miR-423-5p
and mutant miR-423-5p mimics with ncRNA overlapping the
IGSF1 promoter (seed sequence show in lower case, mismatched
bases underlined). (F) RT–qPCR analysis of IGSF1 mRNA expres-
sion following treatment with mutant miR-423-5p mimics. (G) RT–
qPCR analysis of IGSF1 mRNA expression following treatment
with pre-miR-423 mimic. Duplexes were added to cells at
25nM. Error bars indicate SD (n=3). P-values were calculated
using the two-tailed unpaired Student’s t-test with equal variances.
**P<0.01.
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not require full complementarity to recognize their targets
within gene promoters and silence transcription. We also
show that gene silencing can be achieved by miRNAs that
target gene promoters in trans and that a single miRNA
can silence transcription of multiple genes. Finally,
whereas miR-320 was reported to recruit AGO1 to its
target, we ﬁnd that miRNAs with incomplete complemen-
tarity to their targets require AGO2, suggesting the poten-
tial for different silencing mechanisms.
Our work provides insights into the mechanism of
miRNA-induced transcriptional silencing that were not
reported in previous studies. We show that synthetic
miRNAs can recruit AGO2 to ncRNA transcripts that
overlap their target gene promoter, implicating recogni-
tion of ncRNA transcripts in the mechanism of
promoter-targeting miRNAs (Figure 6B). In our model
system, recognition of the target ncRNA by the miRNA
mimic results in moderate reduction in expression of the
ncRNA (Supplementary Figure S5). We do not believe
that the reduction in ncRNA expression is a major
factor in the silencing mechanism. In support of this con-
clusion, we have previously shown that depletion of the
target ncRNA using an RNase H based approach (which
is independent of the RNAi machinery) does not affect PR
expression (14). Instead, we believe that AGO2 is recruit-
ing other protein factors to the PR promoter that affect
transcription of the PR gene. For example, we observed an
increase in H3K9 dimethylation following treatment with
miR-423-5p suggesting that some of these factors may be
chromatin-modifying enzymes (Figure 2D).
Transcriptome studies have revealed that over 70% of
gene promoters are overlapped by ncRNA transcripts
(33). One function of these ncRNAs may be to serve as
targets for miRNAs, which would be consistent with our
previous observation that gene promoter sequences are
enriched with potential miRNA target sites (27).
Transcriptome studies also suggest that over 90% of the
human genome is transcribed into RNA, raising the pos-
sibility that additional non-coding regions of the genome
could serve as targets for miRNAs (33). In support of this
hypothesis, we have recently demonstrated that synthetic
small duplex RNAs can target regions beyond the
30-terminus of protein coding genes and regulate transcrip-
tion of the upstream gene (34). These small RNAs recog-
nize ncRNA transcripts that overlap gene termini in a
manner similar to promoter-targeting small RNAs and
subsequently regulate transcription through long-range
chromosome interactions.
miRNAs have been understood to regulate gene expres-
sion at the post-transcriptional level through recognition
of 30-UTRs within mRNA transcripts. While our demon-
stration of transcriptional silencing involves miRNA
mimics rather than endogenous miRNAs, our results are
robust and are consistent with the hypothesis that
miRNAs can function to recognize ncRNA transcripts
that overlap gene promoters. Sequence speciﬁc recognition
of gene promoters by miRNAs may complement protein
transcription factors. In addition, the ability of small
RNAs to rapidly evolve speciﬁcity for new sequences
would have evolutionary advantages.
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